Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis

Rev Esp Enferm Dig. 2017 Sep;109(9):670. doi: 10.17235/reed.2017.4941/2017.

Abstract

Clostridium difficile (CD) infection is currently the most frequent etiology of nosocomial diarrhea. Besides, its incidence is progressively increasing in ambulatory patients. Inflammatory bowel disease (IBD) is a risk factor of CD infection itself, but also due to the regular immunosuppressive treatment used in these patients. At the present time, fecal transplantation (FT) is a safe and cost-effective alternative if the previous antibiotic treatments have failed. Similar outcomes between patients with IBD and general population have been reported. We present a case of a patient with ulcerative colitis and recurrent CD infection successfully treated with FT.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Clostridioides difficile*
  • Colitis, Ulcerative / complications
  • Colitis, Ulcerative / diagnostic imaging
  • Colitis, Ulcerative / drug therapy*
  • Enterocolitis, Pseudomembranous / complications
  • Enterocolitis, Pseudomembranous / drug therapy
  • Enterocolitis, Pseudomembranous / therapy*
  • Fecal Microbiota Transplantation / methods*
  • Female
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Infliximab / therapeutic use
  • Mesalamine / therapeutic use
  • Middle Aged

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Gastrointestinal Agents
  • Mesalamine
  • Infliximab